June 20, 2021
Business News

Frequency Therapeutics Provides Business Updates and Reports First Quarter 2021 Financial Results

LEXINGTON, Mass.–()–Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases, today announced business updates and financial results for the first quarter ended March 31, 2021.

“As we work to develop a novel medicine for the treatment of the most common form of hearing loss, our initial focus has been to investigate the broadest set of potential conditions and severities through a comprehensive series of probing studies. With data from all of our single administration studies, we have been able to better define the groups of patients that we believe are…

Click here to view the original article.

Related Posts

You might also like ...

Best Couch, Recliner, & Massage Chair Prime Day Deals 2021: Top Early Sectional Sofa, Bean Bag, Leather Recliner & More Sales Collated by The Consumer Post
Sonos Prime Day Deals 2021: Early Sonos One Speaker, Beam Soundbar & More Deals Ranked by The Consumer Post
Prime Day LEGO Deals (2021): Early LEGO Star Wars Millennium Falcon, Harry Potter & LEGO Boost Savings Ranked by Spending Lab